Finding investors was not enough. We had to prove that each fund really backs devices like theirs, and work out who could open the door.
We did not just find investors. We mapped a route to the right people
The team came with 832 investors, nearly all tagged as medtech. Only 40 had a device deal we could prove. The list had to be rebuilt from the device side: funds that had actually backed comparable devices, plus a realistic route into each one.
We started from real transactions. Every investor came from the rounds of device companies like the client's. For each shortlisted fund we read its own site and deal records, then kept it or rejected it, with the reason saved either way.
What the client received was not a fund database but a working map of access: the qualified fund, the proof that it fits, a founder it had backed who can make the introduction, and a first line to open the conversation.